579 related articles for article (PubMed ID: 14635372)
1. The clinical experience with levosimendan in anesthesiology and in the intensive care unit.
Cavana M; Pignataro C; Fraticelli A; Mebazaa A
Ital Heart J; 2003 May; 4 Suppl 2():61S-64S. PubMed ID: 14635372
[TBL] [Abstract][Full Text] [Related]
2. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
Follath F
Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
[TBL] [Abstract][Full Text] [Related]
3. Is calcium sensitization the best strategy to improve myocardial contractility in acute heart failure?
Erhardt LR
Ital Heart J; 2003 May; 4 Suppl 2():27S-33S. PubMed ID: 14635367
[TBL] [Abstract][Full Text] [Related]
4. Levosimendan: a new dual-action drug in the treatment of acute heart failure.
Mebazaa A; Erhardt L
Int J Clin Pract; 2003 Jun; 57(5):410-6. PubMed ID: 12846347
[TBL] [Abstract][Full Text] [Related]
5. Levosimendan: current status and future prospects.
Archan S; Toller W
Curr Opin Anaesthesiol; 2008 Feb; 21(1):78-84. PubMed ID: 18195615
[TBL] [Abstract][Full Text] [Related]
6. Levosimendan in perioperative and critical care patients.
Salmenperä M; Eriksson H
Curr Opin Anaesthesiol; 2009 Aug; 22(4):496-501. PubMed ID: 19502977
[TBL] [Abstract][Full Text] [Related]
7. The utility of levosimendan in the treatment of heart failure.
Lehtonen L; Põder P
Ann Med; 2007; 39(1):2-17. PubMed ID: 17364447
[TBL] [Abstract][Full Text] [Related]
8. Considerations on the efficacy and safety of levosimendan in ischemic heart failure.
Nieminen MS; Sandell EP
Ital Heart J; 2003 May; 4 Suppl 2():39S-44S. PubMed ID: 14635369
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic treatment with levosimendan: a retrospective matched-control study of patients with reduced left ventricular function.
Kolseth SM; Nordhaug DO; Stenseth R; Sellevold O; Kirkeby-Garstad I; Wahba A
Eur J Cardiothorac Surg; 2009 Dec; 36(6):1024-30. PubMed ID: 19592266
[TBL] [Abstract][Full Text] [Related]
10. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
Barraud D; Faivre V; Damy T; Welschbillig S; Gayat E; Heymes C; Payen D; Shah AM; Mebazaa A
Crit Care Med; 2007 May; 35(5):1376-82. PubMed ID: 17414729
[TBL] [Abstract][Full Text] [Related]
11. Levosimendan: implications for clinicians.
McBride BF; White CM
J Clin Pharmacol; 2003 Oct; 43(10):1071-81. PubMed ID: 14517189
[TBL] [Abstract][Full Text] [Related]
12. European experience on the practical use of levosimendan in patients with acute heart failure syndromes.
Follath F; Franco F; Cardoso JS
Am J Cardiol; 2005 Sep; 96(6A):80G-5G. PubMed ID: 16181827
[TBL] [Abstract][Full Text] [Related]
13. Effect of levosimendan on ventricular arrhythmias and prognostic autonomic indexes in patients with decompensated advanced heart failure secondary to ischemic or dilated cardiomyopathy.
Flevari P; Parissis JT; Leftheriotis D; Panou F; Kourea K; Kremastinos DT
Am J Cardiol; 2006 Dec; 98(12):1641-5. PubMed ID: 17145226
[TBL] [Abstract][Full Text] [Related]
14. Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure.
Cleland JG; Nikitin N; McGowan J
Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):9-19. PubMed ID: 15038409
[TBL] [Abstract][Full Text] [Related]
15. Levosimendan: beyond its simple inotropic effect in heart failure.
Antoniades C; Tousoulis D; Koumallos N; Marinou K; Stefanadis C
Pharmacol Ther; 2007 May; 114(2):184-97. PubMed ID: 17363065
[TBL] [Abstract][Full Text] [Related]
16. Successful use of levosimendan in a patient during cardiopulmonary bypass.
Iriz E; Erer D; Unal Y; Zor H; Ozkose Z; Ozdogan ME
J Card Surg; 2007; 22(2):153-6. PubMed ID: 17338755
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.
Stocker CF; Shekerdemian LS; Nørgaard MA; Brizard CP; Mynard JP; Horton SB; Penny DJ
Crit Care Med; 2007 Jan; 35(1):252-9. PubMed ID: 17133188
[TBL] [Abstract][Full Text] [Related]
18. Evidence-based use of levosimendan in different clinical settings.
De Luca L; Colucci WS; Nieminen MS; Massie BM; Gheorghiade M
Eur Heart J; 2006 Aug; 27(16):1908-20. PubMed ID: 16682381
[TBL] [Abstract][Full Text] [Related]
19. Levosimendan: a novel inotropic agent for treatment of acute, decompensated heart failure.
Earl GL; Fitzpatrick JT
Ann Pharmacother; 2005 Nov; 39(11):1888-96. PubMed ID: 16219899
[TBL] [Abstract][Full Text] [Related]
20. Levosimendan infusion improves haemodynamics in elderly heart failure patients undergoing urgent hip fracture repair.
Ponschab M; Hochmair N; Ghazwinian N; Mueller T; Plöchl W
Eur J Anaesthesiol; 2008 Aug; 25(8):627-33. PubMed ID: 18405408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
